Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/3886
| Predicate | Object |
|---|---|
| rdf:type | |
| rdfs:label |
Sodium Chloride (Solution)
|
| dailymed-instance:dosage |
The 50 mL syringe and the 125 mL syringe are intended for Single Patient Use. The volume of the saline flush should be determined for each patient individually based, in part, on the imaging procedure, the location of the vascular access device, the length of tubing between the Mallinckrodt contrast agent power injector and the vascular access device and the recommendations made on the package insert for the contrast agent. Typical Sodium Chloride Injection, USP 0.9% flush volumes following contrast agent administration in adults are 10 to 25 mL per injection atrates not to exceed 10 mL/sec. Use of some Mallinckrodt contrast agent power injectors allows for additional infusion of Sodium Chloride Injection, USP 0.9% to maintain the patency of vascular access. Typical infusion rates used for this purpose are in the range of 0.5 to 1 mL per minute. Infusion rates and flush volumes should be individualized for each patient based on their body weight, fluid status and concomitant medical conditions. Consult the Mallinckrodt contrast agent power injector manual for proper use.<br/>Drug Handling: EXPEL AIR BEFORE USE. Do not use if packaging is damaged, wet or not intact. Do not use if the syringe or its cap is damaged or displaced, or if any leakage is evident. Do not use if solution is hazy, cloudy, discolored or contains particulate matter. Use aseptic technique. Residual air in both the syringe and tubing should be expelled prior to connection with the patient's vascular access. Instructions for assembly and inspection of the Sodium Chloride Injection, USP 0.9% syringes prior to use are printed on this sheet.
|
| dailymed-instance:descripti... |
Sodium Chloride Injection, USP 0.9% is a formulation of sodium chloride in Water for Intravascular Injection. No preservative, antimicrobial agent or buffer is added. Sodium Chloride Injection, USP 0.9% is provided as a sterile, nonpyrogenic, clear, colorless, odorless solution. Each mL of Sodium Chloride Injection, USP 0.9% contains 9 mg of sodium chloride. The pH is 4.5 to 7.0. The osmolarity is 308 mOsm/L (calc.). Sodium Chloride Injection, USP 0.9% is designated chemically as sodium chloride and its molecular formula is NaCl. Its molecular weight is 58.44. Sodium Chloride Injection, USP 0.9% is provided in a 50 mL syringe with a 50 mL fill and a 125 mL syringe with a 125 mL fill. The syringes are for single patient use and are disposable and not meant for reuse.
|
| dailymed-instance:clinicalP... |
Sodium Chloride Injection, USP 0.9% has approximately the same osmotic pressure as plasma.
|
| dailymed-instance:activeIng... | |
| dailymed-instance:contraind... |
None known.
|
| dailymed-instance:supply |
Sodium Chloride Injection, USP 0.9% is a clear, colorless, odorless solution containing 0.9 mg/mL of sodium chloride. Sodium Chloride Injection, USP 0.9% is supplied in 50 and 125 mL syringes containing 50 and 125 mL of solution respectively. Each syringe is sealed with rubber closures and the contents are sterile. The 125 mL syringe is supplied with a luer locknut adapter which is cleared for manufacture and distribution as a device under 510K 862653. The syringes are contained in shipping cartons with the following configurations: 50 mL in plastic syringes in cartons of 10 syringes(NDC Code 0019-1188-75) 125 mL in plastic syringes in cartons of 20 syringes(NDC Code 0019-1188-81) Storage: Store at 25��C (77��F); excursions permitted to 15 to 30��C (59 to 86��F) [See USP Controlled Room Temperature].
|
| dailymed-instance:activeMoi... | |
| dailymed-instance:inactiveI... | |
| dailymed-instance:overdosag... |
Use of Sodium Chloride Injection, USP 0.9% may pose a threat of overdose marked by electrolyte disturbance and/or fluid overload, particularly in pediatric patients and patients with compromised renal or cardiac function. In the event this should occur, discontinue the infusion, reevaluate the patient and institute appropriate corrective action.
|
| dailymed-instance:genericMe... |
Sodium Chloride
|
| dailymed-instance:fullName |
Sodium Chloride (Solution)
|
| dailymed-instance:adverseRe... |
There may be reactions due to solution or technique of administration which include air embolization with stroke, chest pain, and dyspnea, arrhythmia, hypotension, myocardial infarction, sepsis, febrile response, local tenderness, infection at the site of injection, venous thrombosis or phlebitis extending from injection site, extravasation, fluid overload, and hypervolemia.
|
| dailymed-instance:indicatio... |
50 mL Syringe: Sodium Chloride Injection, USP 0.9% is indicated for use in flushing compatible contrast agents through Mallinckrodt intravenous administration sets into indwelling intravascular access devices when delivered manually or by Mallinckrodt Optistar' LE power injector.<br/>125 mL Syringe: Sodium Chloride Injection, USP 0.9% is indicated for use in flushing compatible contrast agents through Mallinckrodt intravenous administration sets into indwelling intravascular access devices only when delivered by the following Mallinckrodt power injectors: Angiomat' Illumena', CT9000', CT9000' ADV, Optistat' and OptiVantage���DH.
|
| dailymed-instance:represent... | |
| dailymed-instance:routeOfAd... | |
| dailymed-instance:name |
Sodium Chloride
|